Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Tin-oxide nanoparticles deposited from a beam: what happens to the composition?

Tchaplyguine M, Wright C, Shavorskiy A, Zhu S, Mikkelä MH, Zhang C, Björneholm O, Mårsell E, Mikkelsen A, Sorensen S, Hetherington CJD, Wallenberg LR.

Phys Chem Chem Phys. 2019 Mar 13;21(11):6287-6295. doi: 10.1039/c8cp06168h.

PMID:
30834904
2.

Metal-passivated PbS nanoparticles: fabrication and characterization.

Tchaplyguine M, Mikkelä MH, Mårsell E, Polley C, Mikkelsen A, Zhang W, Yartsev A, Hetherington CJ, Wallenberg LR, Björneholm O.

Phys Chem Chem Phys. 2017 Mar 8;19(10):7252-7261. doi: 10.1039/c6cp06870g.

PMID:
28239693
3.

Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.

Yong KJ, Basseres DS, Welner RS, Zhang WC, Yang H, Yan B, Alberich-Jorda M, Zhang J, de Figueiredo-Pontes LL, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon YC, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E.

Sci Transl Med. 2016 Aug 3;8(350):350ra104. doi: 10.1126/scitranslmed.aad6066.

PMID:
27488898
4.

C/EBPα is required for development of dendritic cell progenitors.

Welner RS, Bararia D, Amabile G, Czibere A, Benoukraf T, Bach C, Wansa KD, Ye M, Zhang H, Iino T, Hetherington CJ, Akashi K, Tenen DG.

Blood. 2013 May 16;121(20):4073-81. doi: 10.1182/blood-2012-10-463448. Epub 2013 Apr 1.

5.

Electron image series reconstruction of twin interfaces in InP superlattice nanowires.

Ek M, Borgström MT, Karlsson LS, Hetherington CJ, Wallenberg LR.

Microsc Microanal. 2011 Oct;17(5):752-8. doi: 10.1017/S1431927611000493. Epub 2011 Sep 8.

PMID:
21899810
6.

RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element.

Levantini E, Lee S, Radomska HS, Hetherington CJ, Alberich-Jorda M, Amabile G, Zhang P, Gonzalez DA, Zhang J, Basseres DS, Wilson NK, Koschmieder S, Huang G, Zhang DE, Ebralidze AK, Bonifer C, Okuno Y, Gottgens B, Tenen DG.

EMBO J. 2011 Aug 26;30(19):4059-70. doi: 10.1038/emboj.2011.285.

7.

High-resolution TEM and the application of direct and indirect aberration correction.

Hetherington CJ, Chang LY, Haigh S, Nellist PD, Gontard LC, Dunin-Borkowski RE, Kirkland AI.

Microsc Microanal. 2008 Feb;14(1):60-7. doi: 10.1017/S1431927608080148. Epub 2008 Jan 3.

PMID:
18171500
8.

Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.

Wouters BJ, Jordà MA, Keeshan K, Louwers I, Erpelinck-Verschueren CA, Tielemans D, Langerak AW, He Y, Yashiro-Ohtani Y, Zhang P, Hetherington CJ, Verhaak RG, Valk PJ, Löwenberg B, Tenen DG, Pear WS, Delwel R.

Blood. 2007 Nov 15;110(10):3706-14. Epub 2007 Aug 1.

9.

Aberration-corrected imaging of active sites on industrial catalyst nanoparticles.

Gontard LC, Chang LY, Hetherington CJ, Kirkland AI, Ozkaya D, Dunin-Borkowski RE.

Angew Chem Int Ed Engl. 2007;46(20):3683-5. No abstract available.

PMID:
17387674
10.

Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.

Kobayashi S, Shimamura T, Monti S, Steidl U, Hetherington CJ, Lowell AM, Golub T, Meyerson M, Tenen DG, Shapiro GI, Halmos B.

Cancer Res. 2006 Dec 1;66(23):11389-98.

11.

C/EBPbeta is required for 'emergency' granulopoiesis.

Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, Imanishi J, Akashi K, Tenen DG.

Nat Immunol. 2006 Jul;7(7):732-9. Epub 2006 Jun 4.

PMID:
16751774
12.

A versatile double aberration-corrected, energy filtered HREM/STEM for materials science.

Hutchison JL, Titchmarsh JM, Cockayne DJ, Doole RC, Hetherington CJ, Kirkland AI, Sawada H.

Ultramicroscopy. 2005 Apr;103(1):7-15. Epub 2004 Dec 29.

PMID:
15777595
13.

Shortness of breath.

Dawson JS, Hetherington CJ.

Postgrad Med J. 2004 Nov;80(949):679, 681. No abstract available.

14.

Electron microscopy observations on the role of twinning in the evolution of microstructures.

Dahmen U, Hetherington CJ, Radmilovic V, Johnson E, Xiao SQ, Luo CP.

Microsc Microanal. 2002 Aug;8(4):247-56. Review.

PMID:
12533222
15.

Focus on emergency departments to reduce delays in thrombolysis.

Hetherington CJ, Doyle P, Kayani JA, Gorman DF.

BMJ. 2002 Oct 19;325(7369):901. No abstract available.

16.

Dysregulation of protein modification by ISG15 results in brain cell injury.

Ritchie KJ, Malakhov MP, Hetherington CJ, Zhou L, Little MT, Malakhova OA, Sipe JC, Orkin SH, Zhang DE.

Genes Dev. 2002 Sep 1;16(17):2207-12.

17.

Imaging columns of the light elements carbon, nitrogen and oxygen with sub Angstrom resolution.

Kisielowski C, Hetherington CJ, Wang YC, Kilaas R, O'Keefe MA, Thust A.

Ultramicroscopy. 2001 Nov;89(4):243-63.

PMID:
11766981
18.

Sub-Angstrom high-resolution transmission electron microscopy at 300 keV.

O'Keefe MA, Hetherington CJ, Wang YC, Nelson EC, Turner JH, Kisielowski C, Malm JO, Mueller R, Ringnalda J, Pan M, Thust A.

Ultramicroscopy. 2001 Nov;89(4):215-41.

PMID:
11766980
19.

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.

Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ, Burel SA, Lagasse E, Weissman IL, Akashi K, Zhang DE.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10398-403.

20.

AML1 and AML1 fusion protein AML1-ETO in myeloid gene regulation and leukemogenesis.

Zhang DE, Burel S, Zhou L, Hetherington CJ, Yuan Y.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):368-76. No abstract available.

PMID:
11259158
21.

Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.

Rhoades KL, Hetherington CJ, Harakawa N, Yergeau DA, Zhou L, Liu LQ, Little MT, Tenen DG, Zhang DE.

Blood. 2000 Sep 15;96(6):2108-15.

PMID:
10979955
22.
23.

Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18).

Schwer H, Liu LQ, Zhou L, Little MT, Pan Z, Hetherington CJ, Zhang DE.

Genomics. 2000 Apr 1;65(1):44-52. Erratum in: Genomics. 2007 Mar;89(3):439.

PMID:
10777664
24.

AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter.

Libermann TA, Pan Z, Akbarali Y, Hetherington CJ, Boltax J, Yergeau DA, Zhang DE.

J Biol Chem. 1999 Aug 27;274(35):24671-6.

25.
26.

Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice.

Hetherington CJ, Kingsley PD, Crocicchio F, Zhang P, Rabin MS, Palis J, Zhang DE.

J Immunol. 1999 Jan 1;162(1):503-9.

27.

Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.

Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, Zhang DE.

Mol Cell Biol. 1998 Jul;18(7):3915-25.

28.

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marín-Padilla M, Tenen DG, Speck NA, Zhang DE.

Nat Genet. 1997 Mar;15(3):303-6.

PMID:
9054947
29.

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.

Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG.

Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):569-74.

30.

Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.

Rhoades KL, Hetherington CJ, Rowley JD, Hiebert SW, Nucifora G, Tenen DG, Zhang DE.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11895-900.

31.

Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter.

Chen H, Zhang P, Radomska HS, Hetherington CJ, Zhang DE, Tenen DG.

J Biol Chem. 1996 Jun 28;271(26):15743-52.

32.

CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter.

Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW, Tenen DG.

Mol Cell Biol. 1996 Mar;16(3):1231-40.

33.

Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters.

Zhang DE, Hohaus S, Voso MT, Chen HM, Smith LT, Hetherington CJ, Tenen DG.

Curr Top Microbiol Immunol. 1996;211:137-47. Review.

PMID:
8585944
34.

PU.1 (Spi-1) autoregulates its expression in myeloid cells.

Chen H, Ray-Gallet D, Zhang P, Hetherington CJ, Gonzalez DA, Zhang DE, Moreau-Gachelin F, Tenen DG.

Oncogene. 1995 Oct 19;11(8):1549-60.

PMID:
7478579
35.
36.

Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.

Zhang DE, Hetherington CJ, Gonzalez DA, Chen HM, Tenen DG.

J Immunol. 1994 Oct 1;153(7):3276-84.

PMID:
7522257
37.

Sp1 is a critical factor for the monocytic specific expression of human CD14.

Zhang DE, Hetherington CJ, Tan S, Dziennis SE, Gonzalez DA, Chen HM, Tenen DG.

J Biol Chem. 1994 Apr 15;269(15):11425-34.

38.
39.

The nature and origin of interstellar diamond.

Blake DF, Freund F, Krishnan KF, Echer CJ, Shipp R, Bunch TE, Tielens AG, Lipari RJ, Hetherington CJ, Chang S.

Nature. 1988 Apr 14;332(6165):611-3.

PMID:
11536600

Supplemental Content

Loading ...
Support Center